Omeros Corp on Monday reported positive results from a six-patient study of its investigational treatment for Acute Respiratory Distress Syndrome caused by COVID-19.

The company said all the six patients, who needed mechanical ventilation before treatment, recovered and were discharged from hospital.

A manuscript detailing the results of the study has been accepted for publication in the peer-reviewed journal Immunobiology, Omeros said.

Shares of the company soared 44% to $20.25 in premarket trading.

The news comes as efforts to find a cure for the coronavirus continue around the world.

Pharmaceutical giant CIPLA has manufactured thousands of dosages of the anti-viral drug Remdesivir, which has been shown to shorten recovery time for COVID-19 patients.

CIPLA was granted a licence to manufacture after the drug was first tested by the United States’ Food and Drug Administration (FDA) in May.

The pharmaceutical giant now manufactures and distributes Remdesivir to 127 countries. South Africa is among those countries.

SABC News correspondent Patrick Foknreeports on promising COVID-19 vaccine trials: